News | February 10, 2026
Zydus Lifesciences reports strong Q3 & 9M FY26 growth
Revenue from operations surged 30% year-on-year to Rs. 68,645 million
Revenue from operations surged 30% year-on-year to Rs. 68,645 million
EYRA features intuitive software, automation readiness, and the ability to detect dozens of analytes simultaneously with minimal hands-on time
The partnership initially will focus on cardiovascular and kidney diseases
Cidara will become a wholly owned subsidiary of Merck and the common stock of Cidara will no longer be listed or traded on the Nasdaq Global Market
Syrma Johari is a globally recognised medical device engineering and manufacturing organisation
This agreement will enhance Lupin’s gastroenterology portfolio and expand its presence in emerging markets
_Logo_256_384.png){kind=logo}
The Vital Shape panels provide tiered assessments to detect obesity-related risks early
VitiPure serves as essential solubilizers, emulsifiers, and bioavailability enhancers in drug formulations
The platform integrates with CT imaging and uses deep learning models to generate a 3D digital twin of lung anatomy
Subscribe To Our Newsletter & Stay Updated
